Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

European Innovation Council · Running

SONOCRAFT High-throughput ultrasound-based volumetric 3D printing for tissue engineering

Coordinator
Universitat De Barcelona, Spain
Runs
1 April 2025 to 31 March 2029
Status
Running
EU funding
€3.0m
Total cost
€3.0m
Partners
9 organisations in 6 countries
Type
European Innovation Council
Grant agreement
101187842

What the project is doing

In the project's own words, from its summary on CORDIS.

Cardiovascular diseases are the leading cause of death globally. Efficient drug testing and disease models are needed to reduce their death toll. Myocardial cell constructs, e.g. spheroids, organoids, or organs on a chip, hold promise as disease models and can reduce animal testing. Unfortunately, cell constructs often lack the natural spatial complexity of their in-vivo counterparts, and consequently the cells remain immature and non-differentiated.

Although, 3D printing offers great flexibility regarding the printed structure some limitations apply: the printing process is either slow, or not suited for printing the small-scale nested structures needed to create viable and functional myocardial cell constructs. To 3D bio print viable myocardial cell constructs, we must therefore break through several roadblocks limiting the potential of bioprinting. Our solution, coined SONOCRAFT, combines rapid volumetric 3D printing technology with ultrasonic particle manipulation to create centimetre-long aligned cardiac constructs within hydrogels.

An artificial vasculature, incorporated within the hydrogel matrix, assures perfusion with oxygen and nutrients. Acoustic particle manipulation our tool of choice for cell manipulation as it is cheap, biocompatible, label-free and achieves the required resolution. To reach the objectives SonoPrint is equipped with a range of advanced features: (i) an acoustophoresis chamber for precise cell patterning in 3D; (ii) microfluidic nozzles for injecting multiple cell types; (iii) moveable printheads for flexible cell deposition; (iv) a temperature-controlled cell culture incubator; and (v) full automation for user-friendly operation.

The visionary SONOCRAFT holds potential to transform tissue engineering, regenerative medicine, drug screening, and disease modelling with its technological breakthroughs overcoming current limitations in the field.

Who is involved

OrganisationCityCountryRole
Universitat De BarcelonaBarcelonaSpainCoordinator
Eidgenoessische Technische Hochschule ZuerichZuerichSwitzerlandAssociatedpartner
Universitaet BernBernSwitzerlandAssociatedpartner
Black Drop Biodrucker GmbHAachenGermanyParticipant
Dwi Leibniz-Institut Fur Interaktive Materialien eVAachenGermanyParticipant
Universitaet MuensterMuensterGermanyParticipant
Idryma Epistimon Kai Erevnas I.k.e.IraklionGreeceParticipant
Experian LdaPortoPortugalParticipant
Lunds UniversitetLundSwedenParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI